How Are You Managing DFUs? Evolution of therapies across the continuum of careIn Canada, it is estimated 11 million people live with diabetes, with a new diagnosis every 3 minutes1. Of the 11 million, 15-25% of them will suffer from foot ulceration2. Patients with Diabetic Foot Ulcers (DFUs) are 15 to 40% more likely to require foot lower-leg amputation compared to the general population1. Outside of the quality of life impact for DFU patients post-amputation, they also have a 50% five-year post-amputation mortality rate3. This number is higher than breast cancer and prostate cancer. Join Dr. Paul Kim as he discusses the new paradigm shift in DFU treatment and the concept of limb function preservation, along with the proactive adoption of new advanced wound treatment therapies to increase DFU healing success rates. Learning Objectives • Explore the drivers of care and how they impact your practice Paul J. Kim is the Medical Director of the Wound Program at University of Texas Southwestern Clements University Hospital, Dallas, Texas. He has the rank of Professor in the Department of Plastic Surgery and Orthopedic Surgery. He is also a Fellow of the American College of Foot and Ankle Surgeons.
1. Botros et al. Best Practice Recommendations for the Prevention and Management of Diabetic Foot Ulcers. Foundations of Best Practice for Skin and Wound Management. 2017. https://www.woundscanada.ca/docman/public/health-care-professional/bpr-workshop/895-wc-bpr-prevention-and-management-of-diabetic-foot-ulcers-1573r1e-final/file When
June 10th, 2019 from 4:00 PM to 5:00 PM
Location
Online Webinar - Link will be emailed to all registrants 24 hours before the webinar If you do not receive this notification, please email info@woundscanada.ca ON Canada |